Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.1100
+0.0150 (15.79%)
At close: Mar 20, 2026
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 34.78 million as of March 20, 2026. Its market cap has increased by 146.80% in one year.
Market Cap
34.78M
Enterprise Value
155.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 34.78M, an increase of 51.61%. That is a compound annual growth rate of 1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 34.78M | 20.94% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 56.11M |
| Sernova Biotherapeutics | 55.64M |
| Defence Therapeutics | 45.35M |
| MedMira | 45.33M |
| BriaCell Therapeutics | 44.88M |
| Microbix Biosystems | 34.56M |
| Devonian Health Group | 34.30M |
| Telescope Innovations | 27.88M |